NCT05982847 National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa
| NCT ID | NCT05982847 |
| Status | Recruiting |
| Phase | — |
| Sponsor | North-West University, South Africa |
| Condition | Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 22,464 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2028-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 22,464 participants in total. It began in 2024-04-01 with a primary completion date of 2028-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Childhood Hypertension Consortium of South Africa (CHCSA) was established to foster relationships between the healthcare sector and schools through community engagement and outreach as well as contributing to the decolonization of normative paediatric blood pressure reference values. To date, there has been no nation-wide project in South Africa to determine nationally representative normal blood pressure reference values, nor to estimate the true prevalence of hypertension in the paediatric population of the country. This study will provide critical information on the understanding of blood pressure and hypertension in children, especially of African ancestry. Not only will this effort contribute to the development of the first nationally representative normal reference values of blood pressure but will also benefit healthcare providers in the sector with a clear guideline on the management of high blood pressure in children as developed by experts working with these challenges daily.
Eligibility Criteria
Inclusion Criteria: * All children between ages 5-\<18 years * All children with voluntary assent/consent and parent's permission Exclusion Criteria: * circumstances interfere with the participant's ability to give informed consent (diminished understanding or comprehension, or any language barriers that may pose potential risk in participation under false expectations) * randomly selected children who choose not to participate (lack of assent/consent), even if parent's permission was received, * conditions that interfere with a patient's ability to follow study guidelines, e.g., the use of drugs, alcohol or tobacco products * ages \>18 years or under 5 years * Children will be excluded from the analysis for the determination of normative reference values for blood pressure and anthropometry if taking certain concomitant medication(s) that may affect their blood pressure, or any underlying disease e.g., chronic kidney disease, chronic heart disease etc. that may raise blood pressure.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05982847 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 18 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05982847 currently recruiting?
Yes, NCT05982847 is actively recruiting participants. Contact the research team at ruan.kruger@nwu.ac.za for enrollment information.
Where is the NCT05982847 trial being conducted?
This trial is being conducted at Mthatha, South Africa, Port Elizabeth, South Africa, Bloemfontein, South Africa, Johannesburg, South Africa and 7 additional locations.
Who is sponsoring the NCT05982847 clinical trial?
NCT05982847 is sponsored by North-West University, South Africa. The trial plans to enroll 22,464 participants.